Results 171 to 180 of about 9,093 (212)
Some of the next articles are maybe not open access.

Nasal Decongestants

Drugs, 1981
When a patient presents with nasal obstruction a correct diagnosis must be made. Treatment may not always be required, and the need for intervention should be balanced against the risks of therapy. If the patient has an acute problem, such as the common cold or sinusitis, a topical decongestant may be the most immediately effective remedy, but this ...
D W, Empey, K T, Medder
openaire   +2 more sources

Selecting a Decongestant

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1993
Antihistamines and decongestants often are used interchangeably and in combination for a variety of upper respiratory illnesses ranging from allergic rhinitis to the common cold; yet, these two classes of drugs have distinct therapeutic actions. When administered alone, antihistamines are of no value in reducing nasal stuffiness.
openaire   +2 more sources

Effects of Ocular Decongestants

Archives of Ophthalmology, 1980
Eight widely used commercially available ocular decongestants were compared on the basis of vasoconstrictive effectiveness. The ability of these preparations to counteract histamine-induced erythema and to block its recurrence when rechallenged after one hour was evaluated in six human subjects in seven sessions.
M B, Abelson   +2 more
openaire   +2 more sources

Antihistamines and decongestants

Otolaryngology–Head and Neck Surgery, 1992
Drug therapy for allergic rhinitis is used either to prevent symptoms from occurring by short‐circuiting the reaction and thus inhibiting the production of chemical mediators or to control symptoms after the target organs have been stimulated by these mediators.
openaire   +2 more sources

Pharmacokinetics of Oral Decongestants

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1993
Only three drugs are commonly used as oral decongestants—phenylpropanolamine (PPA), pseudoephedrine (PDE), and phenylephrine (PE). They are all chiral drugs that exist as stereoisomers. It is possible that each enantiomer can reflect significant enantioselective differences with regard to both pharmacokinetic and pharmacodynamic effects.
I, Kanfer, R, Dowse, V, Vuma
openaire   +2 more sources

[Complex decongestive therapy].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2016
The amount of physical pressure plays an important role in complex decongestive therapy (CDT). As a function of pressure, microcirculation takes place between blood vessels and tissue. As part of the total lymphatic system, lymphatic vessels transport the lymphatic load from the interstitial space to the blood stream.
B, Heinig, U, Wollina
openaire   +2 more sources

Decongestion (instead of ultrafiltration?)

Current Opinion in Cardiology
Purpose of review To summarize the contemporary evidence on decongestion strategies in patients with acute heart failure (AHF). Recent findings While loop diuretic therapy has remained the backbone of decongestive treatment in AHF, multiple randomized clinical trials suggest that ...
Art, Schuermans, Frederik H, Verbrugge
openaire   +2 more sources

Complex Decongestive Therapy

Phlebologie, 2015
Complex decongestive therapy (CPT) comprises two successive stages: an intensive phase to reduce lymphedema volume and a maintenance phase to stabilize lymphedema volume. Compression (low-stretch bandage, elastic garment) is the cornerstone of lymphedema treatment. Exercises under the supervision of a trained therapist, nail and skin care, manual lymph
openaire   +2 more sources

Decongestive Lymphatic Therapy

2018
Lymphoedema is a chronic condition affecting millions worldwide. Decongestive lymphatic therapy (DLT) is accepted as the treatment of choice for managing a patient’s symptoms and swelling. Successful treatment can also impact upon the patient’s functional status and quality of life (QoL).
Kristiana Gordon, Peter S. Mortimer
openaire   +1 more source

Nose Drops Versus Oral Decongestants

Postgraduate Medicine, 1970
The physician prescribing nose drops or oral decongestants should be mindful of how readily the complex physiologic function of the nasal passages can be altered. Quite enough rhinitis medicamentosa is already produced by the drops and sprays people use without prescription.
openaire   +2 more sources

Home - About - Disclaimer - Privacy